{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:40:00Z","timestamp":1794674400617,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR19-CE14-0041-02"],"award-info":[{"award-number":["ANR19-CE14-0041-02"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM EQU202203014642"],"award-info":[{"award-number":["FRM EQU202203014642"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent data have shown that liver fibrosis can regress even at later stages of cirrhosis and shifting the immune response from pro-inflammatory towards a resolutive profile is considered as a promising option. The immune regulatory networks that govern the shift of the inflammatory phenotype and thus potential reversal of liver fibrosis are lesser known. Here we show that in precision-cut human liver slices obtained from patients with end-stage fibrosis and in mouse models, inhibiting Mucosal-Associated Invariant T (MAIT) cells using pharmacological or antibody-driven approaches, limits fibrosis progression and even regresses fibrosis, following chronic toxic- or non-alcoholic steatohepatitis (NASH)-induced liver injury. Mechanistic studies, combining RNA sequencing, in vivo functional studies (performed in male mice) and co-culture experiments indicate that disruption of the MAIT cell-monocyte\/macrophage interaction results in resolution of fibrosis both by increasing the frequency of restorative Ly6C<jats:sup>lo<\/jats:sup> at the expenses of pro-fibrogenic Ly6C<jats:sup>hi<\/jats:sup> monocyte-derived macrophages and promoting an autophagic phenotype in both subsets. Thus, our data show that MAIT cell activation and the consequential phenotype shift of liver macrophages are important pathogenic features of liver fibrosis and could be targeted by anti-fibrogenic therapy.<\/jats:p>","DOI":"10.1038\/s41467-023-37453-5","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:50:55Z","timestamp":1680501055000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2614-7452","authenticated-orcid":false,"given":"Morgane","family":"Mabire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Hammoutene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Ca\u00ebr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola Al","family":"Sayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Cadoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Allaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6052-5536","authenticated-orcid":false,"given":"Tristan","family":"Thibault-Sogorb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3161-7719","authenticated-orcid":false,"given":"Olivier","family":"Lantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Goodhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"de la Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6770-4561","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Gilgenkrantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0053-7807","authenticated-orcid":false,"given":"Sophie","family":"Lotersztajn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"key":"37453_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin, P. et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet 381, 468\u2013475 (2013).","journal-title":"Lancet"},{"key":"37453_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","volume":"75","author":"SL Friedman","year":"2022","unstructured":"Friedman, S. L. & Pinzani, M. Hepatic fibrosis 2022: Unmet needs and a blueprint for the future. Hepatology 75, 473\u2013488 (2022).","journal-title":"Hepatology"},{"key":"37453_CR3","doi-asserted-by":"publisher","first-page":"C789","DOI":"10.1152\/ajpcell.00230.2013","volume":"305","author":"A Mallat","year":"2013","unstructured":"Mallat, A. & Lotersztajn, S. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am. J. Physiol. Cell Physiol. 305, C789\u2013C799 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"37453_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol. 18, 151\u2013166 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"37453_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki, E. & Schwabe, R. F. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 61, 1066\u20131079 (2015).","journal-title":"Hepatology"},{"key":"37453_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2022.06.012","volume":"77","author":"M Peiseler","year":"2022","unstructured":"Peiseler, M. et al. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits. J. Hepatol. 77, 1136\u20131160 (2022).","journal-title":"J. Hepatol."},{"key":"37453_CR7","doi-asserted-by":"publisher","first-page":"867940","DOI":"10.3389\/fendo.2022.867940","volume":"13","author":"JK Carter","year":"2022","unstructured":"Carter, J. K. & Friedman, S. L. Hepatic stellate cell-immune interactions in NASH. Front. Endocrinol. 13, 867940 (2022).","journal-title":"Front. Endocrinol."},{"key":"37453_CR8","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran, P. et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc. Natl Acad. Sci. USA 109, E3186\u2013E3195 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37453_CR9","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke, F. Targeting hepatic macrophages to treat liver diseases. J. Hepatol. 66, 1300\u20131312 (2017).","journal-title":"J. Hepatol."},{"key":"37453_CR10","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","volume":"575","author":"P Ramachandran","year":"2019","unstructured":"Ramachandran, P. et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature 575, 512\u2013518 (2019).","journal-title":"Nature"},{"key":"37453_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41577-019-0191-y","volume":"19","author":"A Toubal","year":"2019","unstructured":"Toubal, A., Nel, I., Lotersztajn, S. & Lehuen, A. Mucosal-associated invariant T cells and disease. Nat. Rev. Immunol. 19, 643\u2013657 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"37453_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature01433","volume":"422","author":"E Treiner","year":"2003","unstructured":"Treiner, E. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164\u2013169 (2003).","journal-title":"Nature"},{"key":"37453_CR13","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nature11605","volume":"491","author":"L Kjer-Nielsen","year":"2012","unstructured":"Kjer-Nielsen, L. et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717\u2013723 (2012).","journal-title":"Nature"},{"key":"37453_CR14","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/ni.1890","volume":"11","author":"L Le Bourhis","year":"2010","unstructured":"Le Bourhis, L. et al. Antimicrobial activity of mucosal-associated invariant T cells. Nat. Immunol. 11, 701\u2013708 (2010).","journal-title":"Nat. Immunol."},{"key":"37453_CR15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.molimm.2020.11.017","volume":"129","author":"N Veerapen","year":"2021","unstructured":"Veerapen, N., Hobrath, J., Besra, A. K. & Besra, G. S. Chemical insights into the search for MAIT cells activators. Mol. Immunol. 129, 114\u2013120 (2021).","journal-title":"Mol. Immunol."},{"key":"37453_CR16","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.20140484","volume":"211","author":"SB Eckle","year":"2014","unstructured":"Eckle, S. B. et al. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells. J. Exp. Med. 211, 1585\u20131600 (2014).","journal-title":"J. Exp. Med."},{"key":"37453_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/hep.29782","volume":"68","author":"K Bottcher","year":"2018","unstructured":"Bottcher, K. et al. MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation. Hepatology 68, 172\u2013186 (2018).","journal-title":"Hepatology"},{"key":"37453_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04450-y","volume":"9","author":"P Hegde","year":"2018","unstructured":"Hegde, P. et al. Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver. Nat. Commun. 9, 2146 (2018).","journal-title":"Nat. Commun."},{"key":"37453_CR19","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1080\/15548627.2015.1058473","volume":"11","author":"J Lodder","year":"2015","unstructured":"Lodder, J. et al. Macrophage autophagy protects against liver fibrosis in mice. Autophagy 11, 1280\u20131292 (2015).","journal-title":"Autophagy"},{"key":"37453_CR20","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/gutjnl-2018-316137","volume":"68","author":"A Habib","year":"2019","unstructured":"Habib, A. et al. Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver. Gut 68, 522\u2013532 (2019).","journal-title":"Gut"},{"key":"37453_CR21","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.29544","volume":"67","author":"O Krenkel","year":"2018","unstructured":"Krenkel, O. et al. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 67, 1270\u20131283 (2018).","journal-title":"Hepatology"},{"key":"37453_CR22","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1172\/JCI82424","volume":"125","author":"Y Cui","year":"2015","unstructured":"Cui, Y. et al. Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation. J. Clin. Invest. 125, 4171\u20134185 (2015).","journal-title":"J. Clin. Invest."},{"key":"37453_CR23","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.2353\/ajpath.2009.080632","volume":"174","author":"C Mitchell","year":"2009","unstructured":"Mitchell, C. et al. Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice. Am. J. Pathol. 174, 1766\u20131775 (2009).","journal-title":"Am. J. Pathol."},{"key":"37453_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13889","volume":"7","author":"P Holland","year":"2016","unstructured":"Holland, P. et al. HS1BP3 negatively regulates autophagy by modulation of phosphatidic acid levels. Nat. Commun. 7, 13889 (2016).","journal-title":"Nat. Commun."},{"key":"37453_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.immuni.2020.09.009","volume":"53","author":"F Legoux","year":"2020","unstructured":"Legoux, F., Salou, M. & Lantz, O. MAIT cell development and functions: the microbial connection. Immunity 53, 710\u2013723 (2020).","journal-title":"Immunity"},{"key":"37453_CR26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2159-8290.CD-19-0569","volume":"10","author":"J Yan","year":"2020","unstructured":"Yan, J. et al. MAIT cells promote tumor initiation, growth, and metastases via tumor MR1. Cancer Discov. 10, 124\u2013141 (2020).","journal-title":"Cancer Discov."},{"key":"37453_CR27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/mi.2016.39","volume":"10","author":"Z Chen","year":"2017","unstructured":"Chen, Z. et al. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol. 10, 58\u201368 (2017).","journal-title":"Mucosal Immunol."},{"key":"37453_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17307-0","volume":"11","author":"A Toubal","year":"2020","unstructured":"Toubal, A. et al. Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity. Nat. Commun. 11, 3755 (2020).","journal-title":"Nat. Commun."},{"key":"37453_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki, E. et al. CCR2 promotes hepatic fibrosis in mice. Hepatology 50, 185\u2013197 (2009).","journal-title":"Hepatology"},{"key":"37453_CR30","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","volume":"1","author":"KJ Schwenger","year":"2019","unstructured":"Schwenger, K. J., Clermont-Dejean, N. & Allard, J. P. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep. 1, 214\u2013226 (2019).","journal-title":"JHEP Rep."},{"key":"37453_CR31","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41590-021-00870-z","volume":"22","author":"H Flament","year":"2021","unstructured":"Flament, H. et al. Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity. Nat. Immunol. 22, 322\u2013335 (2021).","journal-title":"Nat. Immunol."},{"key":"37453_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.26607","volume":"59","author":"J Wan","year":"2014","unstructured":"Wan, J. et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 59, 130\u2013142 (2014).","journal-title":"Hepatology"},{"key":"37453_CR33","doi-asserted-by":"crossref","unstructured":"Wan, J. et al. LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling. Sci. Transl. Med. 12, eaaw8523 (2020).","DOI":"10.1126\/scitranslmed.aaw8523"},{"key":"37453_CR34","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","volume":"70","author":"M Allaire","year":"2019","unstructured":"Allaire, M., Rautou, P. E., Codogno, P. & Lotersztajn, S. Autophagy in liver diseases: time for translation? J. Hepatol. 70, 985\u2013998 (2019).","journal-title":"J. Hepatol."},{"key":"37453_CR35","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jhep.2021.02.012","volume":"74","author":"H Gilgenkrantz","year":"2021","unstructured":"Gilgenkrantz, H., Mallat, A., Moreau, R. & Lotersztajn, S. Targeting cell-intrinsic metabolism for antifibrotic therapy. J. Hepatol. 74, 1442\u20131454 (2021).","journal-title":"J. Hepatol."},{"key":"37453_CR36","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1073\/pnas.1110730109","volume":"109","author":"C Zhang","year":"2012","unstructured":"Zhang, C. et al. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc. Natl Acad. Sci. USA 109, 1667\u20131672 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"37453_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/15548627.2015.1023984","volume":"11","author":"P Hsu","year":"2015","unstructured":"Hsu, P. et al. Cardiolipin remodeling by TAZ\/tafazzin is selectively required for the initiation of mitophagy. Autophagy 11, 643\u2013652 (2015).","journal-title":"Autophagy"},{"key":"37453_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"37453_CR39","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41593-020-00718-z","volume":"23","author":"A Chiot","year":"2020","unstructured":"Chiot, A. et al. Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival. Nat. Neurosci. 23, 1339\u20131351 (2020).","journal-title":"Nat. Neurosci."},{"key":"37453_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14090-5","volume":"11","author":"N Gacem","year":"2020","unstructured":"Gacem, N. et al. ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development. Nat. Commun. 11, 198 (2020).","journal-title":"Nat. Commun."},{"key":"37453_CR41","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.devcel.2017.03.003","volume":"41","author":"C Naro","year":"2017","unstructured":"Naro, C. et al. An orchestrated intron retention program in meiosis controls timely usage of transcripts during germ cell differentiation. Dev. Cell 41, 82\u201393.e84 (2017).","journal-title":"Dev. Cell"},{"key":"37453_CR42","doi-asserted-by":"crossref","unstructured":"Traore, M. et al. An embryonic CaVbeta1 isoform promotes muscle mass maintenance via GDF5 signaling in adult mouse. Sci. Transl. Med. 11, eaaw1131 (2019).","DOI":"10.1126\/scitranslmed.aaw1131"},{"key":"37453_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"37453_CR44","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 47, W199\u2013W205 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37453-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T05:53:59Z","timestamp":1680501239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-37453-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["37453"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-37453-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"30 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1830"}}